Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mammalian X chromosome inactivation evolved as a dosage-compensation mechanism for dosage-sensitive genes on the X chromosome

Identifieur interne : 003167 ( Pmc/Corpus ); précédent : 003166; suivant : 003168

Mammalian X chromosome inactivation evolved as a dosage-compensation mechanism for dosage-sensitive genes on the X chromosome

Auteurs : Eugénie Pessia ; Takashi Makino ; Marc Bailly-Bechet ; Aoife Mclysaght ; Gabriel A. B. Marais

Source :

RBID : PMC:3325647

Abstract

How and why female somatic X-chromosome inactivation (XCI) evolved in mammals remains poorly understood. It has been proposed that XCI is a dosage-compensation mechanism that evolved to equalize expression levels of X-linked genes in females (2X) and males (1X), with a prior twofold increase in expression of X-linked genes in both sexes (“Ohno's hypothesis”). Whereas the parity of X chromosome expression between the sexes has been clearly demonstrated, tests for the doubling of expression levels globally along the X chromosome have returned contradictory results. However, changes in gene dosage during sex-chromosome evolution are not expected to impact on all genes equally, and should have greater consequences for dosage-sensitive genes. We show that, for genes encoding components of large protein complexes (≥ 7 members)—a class of genes that is expected to be dosage-sensitive—expression of X-linked genes is similar to that of autosomal genes within the complex. These data support Ohno's hypothesis that XCI acts as a dosage-compensation mechanism, and allow us to refine Ohno's model of XCI evolution. We also explore the contribution of dosage-sensitive genes to X aneuploidy phenotypes in humans, such as Turner (X0) and Klinefelter (XXY) syndromes. X aneuploidy in humans is common and is known to have mild effects because most of the supernumerary X genes are inactivated and not affected by aneuploidy. Only genes escaping XCI experience dosage changes in X-aneuploidy patients. We combined data on dosage sensitivity and XCI to compute a list of candidate genes for X-aneuploidy syndromes.


Url:
DOI: 10.1073/pnas.1116763109
PubMed: 22392987
PubMed Central: 3325647

Links to Exploration step

PMC:3325647

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Mammalian X chromosome inactivation evolved as a dosage-compensation mechanism for dosage-sensitive genes on the X chromosome</title>
<author>
<name sortKey="Pessia, Eugenie" sort="Pessia, Eugenie" uniqKey="Pessia E" first="Eugénie" last="Pessia">Eugénie Pessia</name>
<affiliation>
<nlm:aff id="aff1">Laboratoire de Biométrie et Biologie évolutive, Université Lyon 1,
<institution>Centre National de la Recherche Scientifique</institution>
, Villeurbanne F-69622 cedex,
<country>France</country>
;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Makino, Takashi" sort="Makino, Takashi" uniqKey="Makino T" first="Takashi" last="Makino">Takashi Makino</name>
<affiliation>
<nlm:aff id="aff2">Department of Ecology and Evolutionary Biology, Graduate School of Life Sciences,
<institution>Tohoku University</institution>
, Aoba-ku, Sendai 980-8578,
<country>Japan</country>
;</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff wicri:cut="; and" id="aff3">Smurfit Institute of Genetics,
<institution>University of Dublin</institution>
, Trinity College, Dublin 2,
<country>Ireland</country>
</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Bailly Bechet, Marc" sort="Bailly Bechet, Marc" uniqKey="Bailly Bechet M" first="Marc" last="Bailly-Bechet">Marc Bailly-Bechet</name>
<affiliation>
<nlm:aff id="aff1">Laboratoire de Biométrie et Biologie évolutive, Université Lyon 1,
<institution>Centre National de la Recherche Scientifique</institution>
, Villeurbanne F-69622 cedex,
<country>France</country>
;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Mclysaght, Aoife" sort="Mclysaght, Aoife" uniqKey="Mclysaght A" first="Aoife" last="Mclysaght">Aoife Mclysaght</name>
<affiliation>
<nlm:aff wicri:cut="; and" id="aff3">Smurfit Institute of Genetics,
<institution>University of Dublin</institution>
, Trinity College, Dublin 2,
<country>Ireland</country>
</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Marais, Gabriel A B" sort="Marais, Gabriel A B" uniqKey="Marais G" first="Gabriel A. B." last="Marais">Gabriel A. B. Marais</name>
<affiliation>
<nlm:aff id="aff1">Laboratoire de Biométrie et Biologie évolutive, Université Lyon 1,
<institution>Centre National de la Recherche Scientifique</institution>
, Villeurbanne F-69622 cedex,
<country>France</country>
;</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="aff4">
<institution>Instituto Gulbenkian de Ciência</institution>
, P-2780-156 Oeiras,
<country>Portugal</country>
</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">22392987</idno>
<idno type="pmc">3325647</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325647</idno>
<idno type="RBID">PMC:3325647</idno>
<idno type="doi">10.1073/pnas.1116763109</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">003167</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003167</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Mammalian X chromosome inactivation evolved as a dosage-compensation mechanism for dosage-sensitive genes on the X chromosome</title>
<author>
<name sortKey="Pessia, Eugenie" sort="Pessia, Eugenie" uniqKey="Pessia E" first="Eugénie" last="Pessia">Eugénie Pessia</name>
<affiliation>
<nlm:aff id="aff1">Laboratoire de Biométrie et Biologie évolutive, Université Lyon 1,
<institution>Centre National de la Recherche Scientifique</institution>
, Villeurbanne F-69622 cedex,
<country>France</country>
;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Makino, Takashi" sort="Makino, Takashi" uniqKey="Makino T" first="Takashi" last="Makino">Takashi Makino</name>
<affiliation>
<nlm:aff id="aff2">Department of Ecology and Evolutionary Biology, Graduate School of Life Sciences,
<institution>Tohoku University</institution>
, Aoba-ku, Sendai 980-8578,
<country>Japan</country>
;</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff wicri:cut="; and" id="aff3">Smurfit Institute of Genetics,
<institution>University of Dublin</institution>
, Trinity College, Dublin 2,
<country>Ireland</country>
</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Bailly Bechet, Marc" sort="Bailly Bechet, Marc" uniqKey="Bailly Bechet M" first="Marc" last="Bailly-Bechet">Marc Bailly-Bechet</name>
<affiliation>
<nlm:aff id="aff1">Laboratoire de Biométrie et Biologie évolutive, Université Lyon 1,
<institution>Centre National de la Recherche Scientifique</institution>
, Villeurbanne F-69622 cedex,
<country>France</country>
;</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Mclysaght, Aoife" sort="Mclysaght, Aoife" uniqKey="Mclysaght A" first="Aoife" last="Mclysaght">Aoife Mclysaght</name>
<affiliation>
<nlm:aff wicri:cut="; and" id="aff3">Smurfit Institute of Genetics,
<institution>University of Dublin</institution>
, Trinity College, Dublin 2,
<country>Ireland</country>
</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Marais, Gabriel A B" sort="Marais, Gabriel A B" uniqKey="Marais G" first="Gabriel A. B." last="Marais">Gabriel A. B. Marais</name>
<affiliation>
<nlm:aff id="aff1">Laboratoire de Biométrie et Biologie évolutive, Université Lyon 1,
<institution>Centre National de la Recherche Scientifique</institution>
, Villeurbanne F-69622 cedex,
<country>France</country>
;</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff id="aff4">
<institution>Instituto Gulbenkian de Ciência</institution>
, P-2780-156 Oeiras,
<country>Portugal</country>
</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Proceedings of the National Academy of Sciences of the United States of America</title>
<idno type="ISSN">0027-8424</idno>
<idno type="eISSN">1091-6490</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>How and why female somatic X-chromosome inactivation (XCI) evolved in mammals remains poorly understood. It has been proposed that XCI is a dosage-compensation mechanism that evolved to equalize expression levels of X-linked genes in females (2X) and males (1X), with a prior twofold increase in expression of X-linked genes in both sexes (“Ohno's hypothesis”). Whereas the parity of X chromosome expression between the sexes has been clearly demonstrated, tests for the doubling of expression levels globally along the X chromosome have returned contradictory results. However, changes in gene dosage during sex-chromosome evolution are not expected to impact on all genes equally, and should have greater consequences for dosage-sensitive genes. We show that, for genes encoding components of large protein complexes (≥ 7 members)—a class of genes that is expected to be dosage-sensitive—expression of X-linked genes is similar to that of autosomal genes within the complex. These data support Ohno's hypothesis that XCI acts as a dosage-compensation mechanism, and allow us to refine Ohno's model of XCI evolution. We also explore the contribution of dosage-sensitive genes to X aneuploidy phenotypes in humans, such as Turner (X0) and Klinefelter (XXY) syndromes. X aneuploidy in humans is common and is known to have mild effects because most of the supernumerary X genes are inactivated and not affected by aneuploidy. Only genes escaping XCI experience dosage changes in X-aneuploidy patients. We combined data on dosage sensitivity and XCI to compute a list of candidate genes for X-aneuploidy syndromes.</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">22392987</article-id>
<article-id pub-id-type="pmc">3325647</article-id>
<article-id pub-id-type="publisher-id">201116763</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1116763109</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Evolution</subject>
</subj-group>
</subj-group>
<series-title>From the Cover</series-title>
</article-categories>
<title-group>
<article-title>Mammalian X chromosome inactivation evolved as a dosage-compensation mechanism for dosage-sensitive genes on the X chromosome</article-title>
<alt-title alt-title-type="short">Evolution of X dosage compensation in humans</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pessia</surname>
<given-names>Eugénie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Makino</surname>
<given-names>Takashi</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bailly-Bechet</surname>
<given-names>Marc</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McLysaght</surname>
<given-names>Aoife</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marais</surname>
<given-names>Gabriel A. B.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1">
<sup>a</sup>
Laboratoire de Biométrie et Biologie évolutive, Université Lyon 1,
<institution>Centre National de la Recherche Scientifique</institution>
, Villeurbanne F-69622 cedex,
<country>France</country>
;</aff>
<aff id="aff2">
<sup>b</sup>
Department of Ecology and Evolutionary Biology, Graduate School of Life Sciences,
<institution>Tohoku University</institution>
, Aoba-ku, Sendai 980-8578,
<country>Japan</country>
;</aff>
<aff id="aff3">
<sup>c</sup>
Smurfit Institute of Genetics,
<institution>University of Dublin</institution>
, Trinity College, Dublin 2,
<country>Ireland</country>
; and</aff>
<aff id="aff4">
<sup>d</sup>
<institution>Instituto Gulbenkian de Ciência</institution>
, P-2780-156 Oeiras,
<country>Portugal</country>
</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">
<sup>1</sup>
To whom correspondence should be addressed. E-mail:
<email>gabriel.marais@univ-lyon1.fr</email>
.</corresp>
<fn fn-type="edited-by">
<p>Edited
<xref ref-type="fn" rid="fn1">*</xref>
by Michael Freeling, University of California, Berkeley, CA, and approved February 3, 2012 (received for review October 13, 2011)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: G.A.B.M. designed research; E.P., T.M., and M.B.-B. performed research; T.M. and A.M. contributed new reagents/analytic tools; E.P., M.B.-B., and G.A.B.M. analyzed data; and E.P., A.M., and G.A.B.M. wrote the paper.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>3</day>
<month>4</month>
<year>2012</year>
</pub-date>
<pub-date pub-type="epub">
<day>5</day>
<month>3</month>
<year>2012</year>
</pub-date>
<volume>109</volume>
<issue>14</issue>
<fpage>5346</fpage>
<lpage>5351</lpage>
<self-uri xlink:title="pdf" xlink:type="simple" xlink:href="pnas.201116763.pdf"></self-uri>
<abstract>
<p>How and why female somatic X-chromosome inactivation (XCI) evolved in mammals remains poorly understood. It has been proposed that XCI is a dosage-compensation mechanism that evolved to equalize expression levels of X-linked genes in females (2X) and males (1X), with a prior twofold increase in expression of X-linked genes in both sexes (“Ohno's hypothesis”). Whereas the parity of X chromosome expression between the sexes has been clearly demonstrated, tests for the doubling of expression levels globally along the X chromosome have returned contradictory results. However, changes in gene dosage during sex-chromosome evolution are not expected to impact on all genes equally, and should have greater consequences for dosage-sensitive genes. We show that, for genes encoding components of large protein complexes (≥ 7 members)—a class of genes that is expected to be dosage-sensitive—expression of X-linked genes is similar to that of autosomal genes within the complex. These data support Ohno's hypothesis that XCI acts as a dosage-compensation mechanism, and allow us to refine Ohno's model of XCI evolution. We also explore the contribution of dosage-sensitive genes to X aneuploidy phenotypes in humans, such as Turner (X0) and Klinefelter (XXY) syndromes. X aneuploidy in humans is common and is known to have mild effects because most of the supernumerary X genes are inactivated and not affected by aneuploidy. Only genes escaping XCI experience dosage changes in X-aneuploidy patients. We combined data on dosage sensitivity and XCI to compute a list of candidate genes for X-aneuploidy syndromes.</p>
</abstract>
<kwd-group>
<kwd>Y degeneration</kwd>
<kwd>sex-linked gene expression</kwd>
<kwd>balance hypothesis</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003167 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 003167 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:3325647
   |texte=   Mammalian X chromosome inactivation evolved as a dosage-compensation mechanism for dosage-sensitive genes on the X chromosome
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:22392987" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024